Back

The regenerative therapy with human iPS cells-derived cardiac spheroids and gelatin hydrogel significantly improves cardiac function and cause no lethal arrhythmia in a pig model of heart failure

27 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Cardiac regeneration and repair Stem cells and cell therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Shinji Kawaguchi

Keio University Hospital, Tokyo (Japan)

34 More presentations in this session

Presentation thumbnail
Associate Professor D. D'Amario (Novara, IT)
Abstract
Presentation thumbnail
Miss I. Borrego (Fribourg, CH)
Abstract
Presentation thumbnail
Doctor J. Abe (Sapporo, JP)
Abstract
Presentation thumbnail
Miss E. Andre (Brussels, BE)
Abstract
Presentation thumbnail
Doctor Y. Mu (Urumqi, CN)

Access the full session

Session thumbnail
Poster session 3 - Cardiac regeneration and repair

The Event

Event poster

ESC Congress 2017

27 August 2017 14:00 CET
You may be interested in
thumbnail
Webinar
Induced-pluripotent stem cells (iPSC) technology for cardiac repair
17 March 2022
thumbnail
Congress Presentation
New advanced heart failure (HF) pig model with reduced ejection fraction and clinically relevant cardiopulmonary congestion.
29 June 2021
thumbnail
Congress Presentation
Extracellular vesicles derived from hyaluronic acid primed induced pluripotent stem cell derived mesenchymal stem cell can ameliorate the heart function.
20 May 2023
thumbnail
Congress Presentation
Silicon carbide nanowires preserve human atrial microtissue function and show a preliminary reduction of AF duration in an aged-rat atrial tachypacing model
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources